Surgical management of primary cutaneous melanoma

Ca-A Cancer Journal for Clinicians

Volumn 46, Issue 4, 1996, Pages 217-224

  Urist, Marshall M ^a  

^a Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ADULT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; REVIEW; SKIN BIOPSY; SURVIVAL TIME; TUMOR; TUMOR VOLUME;

EID: 0030054885     PISSN: 00079235     EISSN: None     Source Type: Journal    
DOI: 10.3322/canjclin.46.4.217     Document Type: Review

References (40)

1. Lederman JS, Sober AJ: Does biopsy type influence survival in clinical stage I cutaneous melanoma? J Am Acad Dermatol 1985;13:983-987.
2. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ (eds): Manual for Staging of Cancer, ed 4. Philadelphia, JB Lippincott, 1992.
3. Kopf AW, Gross DF, Rogers GS, et al: Prognostic index for malignant melanoma. Cancer 1987;59:1236-1241.
4. Balch CM, Soong SJ, Milton GW, et al: A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA. and New South Wales, Australia. Ann Surg 1982;196:677-684.
5. Stidham KR, Johnson JF, Seigler HF: Survival superiority of females with melanoma: A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome. Arch Surg 1994;129:316-324.
6. Balch CM, Cascinelli N, Drzewiecki KT, et al: A comparison of prognostic factors worldwide, in Balch CM, Houghton AN, Milton GW, et al (eds): Cutaneous Melanoma. Philadelphia, JB Lippincott, 1992, pp 188-192.
7. Balch CM, Soong SJ, Shaw HM, et al: An analysis of prognostic factors in 8500 patients with cutaneous melanoma, in Balch CM, Houghton AN, Milton GW, et al (eds): Cutaneous Melanoma. Philadelphia, JB Lippincott, 1992, pp 165-187.
8. Soong SJ: A computerized mathematical model and scoring system for predicting outcome in patients with localized melanoma, in Balch CM, Houghton AN, Milton GW, et al (eds): Cutaneous Melanoma. Philadelphia. JB Lippincott, 1992, pp 200-212.
9. Pontikes LA, Temple WJ, Cassar SL, et al: Influence of level and depth on recurrence rate in thin melanomas. Am J Surg 1993;165:225-228.
10. Haffner AC, Garbe C, Burg G, et al: The prognosis of primary and metastasising melanoma: An evaluation of the TNM classification in 2,495 patients. Br J Cancer 1992;66:856-861.
11. Urist MM, Balch CM, Soong SJ, et al: The influ- ence of surgical margins and prognostic factors predicting the risk of local recurrence in 3,445 patients with primary cutaneous melanoma. Cancer 1985;55:1398-1402.
12. Reintgen DS, Vollmer R, Tso CY, Seigier HF: Prognosis for recurrent stage I malignant melanoma. Arch Surg 1987;122:1338-1342.
13. Veronesi U, Cascinelli N, Adamus J, et al: Thin stage I primary cutaneous malignant melanoma: Comparison of excision with margins of 1 or 3 cm. N Engl J Med 1988;318:1159-1162.
14. Balch CM, Urist MM, Karakousis CP, et al: Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm): Results of a multi-institutional randomized surgical trial. Ann Surg 1993;218:262-267.
15. Kenady DE, Brown BW, McBride CM: Excision of underlying fascia with a primary malignant melanoma: Effect on recurrence and survival rates. Surgery 1982;92:615-618.
16. Drzewiecki KT, Andersson AP: Local melanoma recurrences in the scar after limited surgery for primary tumor. World J Surg 1995;19:346-349.
17. Crowley NJ, Seigler HF: The role of elective lymph node dissection in the management of patients with thick cutaneous melanoma. Cancer 1990;66:2522-2527.
18. Reintgen DS, Cox EB, McCarty KS Jr: Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg 1983;198:379-385.
19. Veronesi U, Adamus J, Bandiera DC, et al: Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 1982;49:2420-2430.
20. Sim FH, Taylor WF, Pritchard DJ, Soule EH: Lymphadenectomy in the management of stage I malignant melanoma: A prospective randomized study. Mayo Clin Proc 1986;61:697-705.
21. Balch CM, Soong SJ, Urist MM, Karakousis CP, et al: A prospective randomized surgical trial of 742 melanoma patients comparing the efficacy of elective (immediate) lymph node dissection versus observation. Ann Surg 1996. in press.
22. Calabro A, Singletary SE, Balch CM: Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg 1989;124: 1051-1055.
23. Coit DG, Rogatko A, Brennan MF: Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes: A multivariate analysis. Ann Surg 1991;214:627-636.
24. Morton DL, Wen DR, Wong JH, et al: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
25. Morton DL, Wen DR, Foshag LJ, et al: Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol 1993;11:1751-1756.
26. Fee HJ, Robinson DS, Sample WF, et al: The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: A preliminary study. Surgery 1978;84:626-632.
27. Reintgen D, Cruse CW, Wells K, et al: The orderly progression of melanoma nodal metastases. Ann Surg 1994;220:759-767.
28. Ross MI, Reintgen D, Balch CM: Selective lymphadenectomy: Emerging role of lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol 1993;9:219-223.
29. Wells KE, Cruse CW, Daniels S, et al: The use of lymphoscintigraphy in melanoma of the head and neck. Plast Reconstr Surg 1994;93:757-761.
30. O'Brien CJ, Uren RF, Thompson JF, et al: Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 1995;170:461-466.
31. Godellas CV, Berman CG, Lyman G, et al: The identification and mapping of melanoma regional nodal metastases: Minimally invasive surgery for the diagnosis of nodal metastases. Am Surg 1995;61:97-101.
32. Krag DN, Meijer SJ, Weaver DL, et al: Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995;130:654-658.
33. Balch CM, Soong SJ, Murad TM, et al: A multi-factorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg 1981;193:377-388.
34. Coit D, Sauven P, Brennan M: Prognosis of thick cutaneous melanoma of the trunk and extremity. Arch Surg 1990;125:322-326.
35. Barth RJ Jr, Venzon DJ, Baker AR: The prognosis of melanoma patients with metastases to two or more lymph node areas. Ann Surg 1991;214:125-130.
36. Bevilacqua RG, Coit DC, Rogatko A, et al: Axillary dissection in melanoma: Prognostic variables in node-positive patients. Ann Surg 1990;212:125-131.
37. Karakousis CP, Goumas W, Rao U, Driscoll DL: Axillary node dissection in malignant melanoma. Am J Surg 1991;162:202-207.
38. Kirkwood JM, Strawderman MH, Ernstoff MS, et al: Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group trial EST 1684. J Clin Oncol 1996;14:7-17.
39. Shumate CR, Urist MM, Maddox WA: Melanoma recurrence surveillance: Patient or physician based? Ann Surg 1995;221:566-569.
40. Weiss M, Loprinzi CL, Creagan ET, et al: Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas. JAMA 1995;274:1703-1705.